$52.90 1.1%
TEM Stock Price vs. AI Score
Data gathered: April 25

AI Score



Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

AI Stock Analysis - Tempus AI (TEM)

Analysis generated March 18, 2025. Powered by Chat GPT.

Tempus AI is a leading player in the artificial intelligence sector, specializing in healthcare and precision medicine. Utilizing advanced machine learning and data analytics, Tempus AI aims to revolutionize how medical professionals diagnose and treat diseases. The company’s technology platform integrates clinical and molecular data, providing actionable insights for healthcare providers. With a focus on improving patient outcomes, Tempus AI has been gaining traction in the medical community and has shown consistent growth in terms of revenue and market presence.

Read full AI stock Analysis

Stock Alerts - Tempus AI (TEM)

company logo Tempus AI | April 24
Price is up by 7.9% in the last 24h.
company logo Tempus AI | April 23
Price is up by 9.3% in the last 24h.
company logo Tempus AI | April 22
Price is up by 7.3% in the last 24h.
company logo Tempus AI | April 17
Web Traffic is down by 34.3% over the last month.

About Tempus AI

Tempus AI, Inc operates as a healthcare technology company. It engages in providing next generation sequencing diagnostics, polymerase chain reaction profiling, molecular genotyping, and other anatomic and molecular pathology testing to healthcare providers, pharmaceutical companies, biotechnology companies, researchers, and other third parties.


Tempus AI
Price $52.90
Target Price Sign up
Volume 8,980,000
Market Cap $7B
Year Range $31.83 - $89.44
Dividend Yield 0%
Industry Health Care Services

In the news


Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda EPS
Q4 '24201M79M122M-13M12M-0.080
Q3 '24181M78M103M-76M-51M-0.250
Q2 '24166M94M72M-552M-530M-0.630
Q1 '24146M71M75M-65M-42M
Q4 '23148M66M82M-50M-28M

Insider Transactions View All

Doudna Jennifer A filed to sell 25,740 shares at $48.1.
April 3 '25
Fukushima Ryan filed to sell 904,460 shares at $48.7.
April 3 '25
Fukushima Ryan filed to sell 906,476 shares at $48.
April 3 '25
Fukushima Ryan filed to sell 921,160 shares at $46.
April 3 '25
Gottlieb Scott filed to sell 32,839 shares at $48.7.
April 3 '25

What is the Market Cap of Tempus AI?

The Market Cap of Tempus AI is $7B.

What is the current stock price of Tempus AI?

Currently, the price of one share of Tempus AI stock is $52.90.

How can I analyze the TEM stock price chart for investment decisions?

The TEM stock price chart above provides a comprehensive visual representation of Tempus AI's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Tempus AI shares. Our platform offers an up-to-date TEM stock price chart, along with technical data analysis and alternative data insights.

Does TEM offer dividends to its shareholders?

As of our latest update, Tempus AI (TEM) does not offer dividends to its shareholders. Investors interested in Tempus AI should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.

What are some of the similar stocks of Tempus AI?

Some of the similar stocks of Tempus AI are Abbott Laboratories, HCA Healthcare, Cardinal Health, Henry Schein, and Idexx Laboratories.

.
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



App download

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2025 AltIndex. All rights reserved.